In recent studies, Vadlamudi and colleagues utilized human breast cancer cell lines in vitro to establish a novel signaling pathway involving HER2, phospho-Src Tyr-215 and phospho-FAK Tyr-861 leading to increased cellular motility [18,19]. This evidence concerns the gene PTK2 and breast cancer.